• NICE approves Bayer’s liver cancer drug pharmaphorum
    November 30, 2018
    NICE has given Bayer’s advanced liver cancer therapy Stivarga (regorafenib) the go-ahead after it undertook a rapid review following earlier guidance that rejected the drug......
PharmaSources Customer Service